Sanofi's focus: Experimental medicines
November 19, 2014 at 12:24 PM EST
After drug company Sanofi removed CEO Chris Viehbacher, investors question the future of the company's growth and future.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.